Navigation Links
Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
Date:6/27/2012

HAYWARD, Calif., June 27, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced results from the Phase 2b PEARL-SC clinical study in patients with systemic lupus erythematosus.The purpose of the PEARL-SC study was to identify an effective and safe dose for future phase 3 clinical studies and explore key inclusion criteria and clinical endpoints in an effort to maximize differentiation of blisibimod from currently available therapies.  The 200mg weekly subcutaneous dose of blisibimod demonstrated a strong trend in improved clinical response as early as week 16 (p= 0.14), at the primary endpoint (p=0.15) and throughout week 44 including a statistically significant improvement at week 20 versus placebo (p=0.02).

In a predefined phase 3 target population of severely ill, seropositive lupus patients, defined as SELENA-SLEDAI ≥10 and receiving background corticosteroid medication, a more pronounced effect was seen in the 200mg weekly dose group demonstrating a 13.8% treatment difference compared to placebo at 24 weeks.  In this subgroup, planned for phase 3 studies, separation of clinical response occurred as early as week 8 and was also sustained through week 44.  Results from the 200mg weekly group are presented in Table 1.

"The extensive data in the target severe population from our Phase 2 clinical program supports the initiation of a much smaller yet differentiated Phase 3 registration plan with the selected dose of blisibimod in patients with severe systemic lupus erythematosus.  We have prospectively demonstrated for the first time the possibility for a subcutaneously administered BAFF inhibitor to be used in the treatment of a severe lupus population.  The subgroup of severe pat
'/>"/>

SOURCE Anthera Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
2. Anthera Announces First Quarter 2012 Financial Report and Conference Call
3. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
4. Neuralstem Updates ALS Stem Cell Trial Progress
5. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
6. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
7. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
8. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
9. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
10. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... "Medical Equipment Rental and Leasing - Global Strategic ... This report analyzes the worldwide markets for Medical Equipment ... separate comprehensive analytics for the US, Japan ... of World. Annual estimates and forecasts are ...
(Date:4/17/2015)... ASSESS shows   plasma circulating ... viable alternative to tumour biopsy   IGNITE ... advanced NSCLC   AstraZeneca today presented results from ... DNA (ctDNA) testing for epidermal growth factor receptor (EGFR) mutation ... cancer (NSCLC) in clinical practice. [ 1 ] ...
(Date:4/17/2015)... DETROIT , April 17, 2015  In Detroit, ... the infant mortality rate is two and one half times ... births. Nearly 6 of 10 infants that die in ... These are sobering statistics that Covenant Community Care, a faith-based, ... Detroit, is poised to change thanks to a charitable donation ...
Breaking Medicine Technology:Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4
... Mass., Oct. 5 Hologic, Inc. (Hologic or the ... manufacturer and supplier of premium diagnostics, medical imaging systems ... of women, today announced plans to release its fourth ... 2010 after market close. In conjunction with the release, ...
... NEW YORK, Oct. 5 Reportlinker.com announces that a ... Antidiabetics market forecast ... the antidiabetics market to grow to $34.8 billion in ... the leading franchise from 2012 after patent expiry of ...
Cached Medicine Technology:Hologic to Release Fourth Quarter Fiscal 2010 Operating Results on Monday, November 8, 2010 2Reportlinker Adds Antidiabetics Market Forecast 2
(Date:4/18/2015)... New York (PRWEB) April 18, 2015 ... filed on behalf of individuals who were allegedly ... system continue to move forward in the U.S. District ... dated April 10th, the Court has amended an earlier ... unrelated cases. Among other things, the new amendment permits ...
(Date:4/18/2015)... 18, 2015 “ ArcAngel ” was featured ... a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... safety app. , In a turbulent world, people may ... 911 should always be their first move, but some situations ...
(Date:4/17/2015)... York, NY (PRWEB) April 18, 2015 ... at their facility, rounding out their list of diagnostic ... care center for patients on the Upper East Side ... and running at full capacity. The addition of PET-CT, ... gives their physicians the ability to work with patients ...
(Date:4/17/2015)... 17, 2015 “We have seen healing, a ... past and present,” said Chaplain Shawn Kafader of Friendship Village. ... like they had anything to contribute have created beautiful pieces ... a new art therapy program that was launched to benefit ... student from School of the Art Institute in Chicago, worked ...
(Date:4/17/2015)... April 17, 2015 Enthusiasts of gourmet cuisine ... Saturday, April 25, 2015. The event will be held in ... Food (201 Monroe Ave NW, Grand Rapids, MI 49503) and ... West Michigan area. Patrons are encouraged to savor the food ... fun. , This year’s event will feature seven chefs, including:, ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Healing At Friendship Village Due To Art Therapy 2Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2
... woke up as married men Sunday after a clutch ... weekend. ,The off-field antics of the so-called ... were as much the focus as their husbands and ... there was an almighty fixture pile-up for those celebrities, ...
... flu in more than a year has highlighted growing complacency ... the country, experts said Sunday . A 20-year-old man from ... H5N1 strain a week ago, the communist government said, and ... the virus since last month. ,The country's first ...
... born after embryo biopsy for preimplantation genetic diagnosis (PGD) ... born after artificial reproduction technologies (ART) without PGD. ... at risk of transmitting genetic diseases. Instead of carrying ... pregnancy, in vitro fertilisation (IVF) with intracytoplasmic sperm injection ...
... has found that waiting just two minutes to cut the ... boost as it reduces the risk of blood disorders . ... University in Hamilton, Canada, and involved more than 1,900 newborns. ... university, said that the results showed that as little as ...
... have identified potential chinks in the parasite that causes ... some 12 million people around the world . Their ... cases of leishmaniasis could be a boon for drug ... already slender. ,British-led scientists compared the genetic ...
... her parents and doctors in a perplex state when her weight ... to the normal baby growth chart Kaceys recordings were way beyond ... see her ballooning. I was scared, worried - because the weight ... it was like two, three pounds every week. And it was ...
Cached Medicine News:Health News:WAG Wedding Extravaganza for England Footballers 2Health News:Vietnam Bird Flu Death a Call for Action, Say Experts 2Health News:Vietnam Bird Flu Death a Call for Action, Say Experts 3Health News:Children Born After PGD as Healthy as Kids Born After ART 2Health News:2 Minute Delay in Cutting Cord can Give Babies a 'significant' Health Boost 2Health News:Gene Study Throws Up New Targets for Leishmaniasis 2Health News:Obese Infant Kacey Causes Concern 2
... multi-purpose topical gel contains 10% Povidone Iodine ... action. As a pre-operative prep, Povidone Iodine ... prepping solutions under the patient, thus reducing ... is also approved as a one step ...
... Iodine Prep Solution is appropriate for ... wet soak or spray); disinfecting of ... treatment of lacerations and abrasions. It ... agent in hospital and office procedures, ...
... Aplicare's Prep-Swab Ampule is ... a plastic tube that is ... has an absorbent applicator at ... tube is squeezed to break ...
... can be a valuable tool in standardizing ... items necessary for a procedure are supplied ... continuum of care are easier to be ... sequence of use, allowing the clinician to ...
Medicine Products: